PERRIGO COMPANY PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.4 USD | -2.80% |
|
-2.94% | -17.96% |
| May. 28 | Perrigo Company plc Announces Executive Changes | CI |
| May. 07 | Perrigo's Q1 Adjusted Earnings, Net Sales Drop | MT |
Financials (USD)
| Sales 2024 * | 4.62B | Sales 2025 * | 4.84B | Capitalization | 3.6B |
|---|---|---|---|---|---|
| Net income 2024 * | -73M | Net income 2025 * | 107M | EV / Sales 2024 * | 1.47 x |
| Net Debt 2024 * | 3.21B | Net Debt 2025 * | 3.01B | EV / Sales 2025 * | 1.37 x |
| P/E ratio 2024 * |
-18.2
x | P/E ratio 2025 * |
165
x | Employees | 9,140 |
| Yield 2024 * |
4.17% | Yield 2025 * |
4.44% | Free-Float | 99.66% |
More Fundamentals
* Assessed data
More news
Latest transcript on Perrigo Company plc
More recommendations
More press releases
More news
| 1 day | -2.80% | ||
| 1 week | -2.94% | ||
| Current month | -4.10% | ||
| 1 month | -19.49% | ||
| 3 months | -3.15% | ||
| 6 months | -14.59% | ||
| Current year | -17.96% |
1 week
26.38
28.40
1 month
26.3833.35
Current year
25.7734.60
1 year
25.7740.28
3 years
25.7750.90
5 years
25.7763.86
10 years
25.77215.73
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 23-06-29 | |
Eduardo Bezerra
DFI | Director of Finance/CFO | 49 | 22-05-15 |
Alison Ives
CTO | Chief Tech/Sci/R&D Officer | - | 14-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Orlando Ashford
CHM | Chairman | 55 | 20-12-14 |
Jeffrey Kindler
BRD | Director/Board Member | 68 | 17-02-05 |
Bradley Alford
BRD | Director/Board Member | 67 | 17-02-05 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 18.63% | 13 M€ | -.--% | ||
| 15.31% | 254 M€ | +13.39% | - | |
| 0.66% | 8 M€ | +5.48% | - | |
| 0.46% | 2 M€ | +9.08% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-05 | 26.4 | -2.80% | 2,772,348 |
| 24-06-04 | 27.16 | -1.74% | 1,584,922 |
| 24-06-03 | 27.64 | +0.40% | 2,290,798 |
| 24-05-31 | 27.53 | -0.15% | 1,752,160 |
| 24-05-30 | 27.57 | +1.36% | 2,308,712 |
Delayed Quote Nyse, June 05, 2024 at 04:00 pm EDT
More quotes
Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.
Sector
Pharmaceuticals
Calendar
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
26.4
USD
Average target price
39.5
USD
Spread / Average Target
+49.62%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -17.96% | 3.6B | |
| +42.69% | 749B | |
| +34.11% | 605B | |
| -6.87% | 351B | |
| +18.74% | 328B | |
| +6.76% | 292B | |
| +18.08% | 248B | |
| -3.44% | 214B | |
| +11.35% | 216B | |
| +2.64% | 167B |
- Stock Market
- Equities
- PRGO Stock
